CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-24 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Shares withheld for taxes | −515 | $112.17 | $58K | 26,085 |
| 2020-02-24 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Shares withheld for taxes | −2,404 | $112.17 | $270K | 232,933 |
| 2020-02-24 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Shares withheld for taxes | −432 | $112.17 | $48K | 71,106 |
| 2020-02-24 | Mendez Manuel O. SVP & Chief Commercial Officer | Shares withheld for taxes | −123 | $112.17 | $14K | 29,853 |
| 2020-02-24 | GUINAN MARK Executive Vice President & CFO | Shares withheld for taxes | −653 | $112.17 | $73K | 71,516 |
| 2020-02-18 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Grant or award | +776 | 24,619 | ||
| 2020-02-18 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Grant or award · Non-Qualifed Stock Option (right to buy) | +5,059 | 5,059 | ||
| 2020-02-18 | RUSCKOWSKI STEPHEN H Chairman, President and CEO | Grant or award | +22,288 | 235,337 | ||
| 2020-02-18 | RUSCKOWSKI STEPHEN H Chairman, President and CEO | Grant or award · Non-Qualifed Stock Option (right to buy) | +145,361 | 145,361 | ||
| 2020-02-18 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award | +3,477 | 42,455 | ||
| 2020-02-18 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award · Non-Qualifed Stock Option (right to buy) | +22,677 | 22,677 | ||
| 2020-02-18 | Davis J. E. EVP, General Diagnostics | Grant or award | +6,152 | 42,695 | ||
| 2020-02-18 | Davis J. E. EVP, General Diagnostics | Grant or award · Non-Qualifed Stock Option (right to buy) | +40,120 | 40,120 | ||
| 2020-02-18 | Mendez Manuel O. SVP & Chief Commercial Officer | Grant or award | +5,350 | 29,976 | ||
| 2020-02-18 | Mendez Manuel O. SVP & Chief Commercial Officer | Grant or award · Non-Qualifed Stock Option (right to buy) | +34,887 | 34,887 | ||
| 2020-02-18 | GUINAN MARK Executive Vice President & CFO | Grant or award | +6,152 | 72,169 | ||
| 2020-02-18 | GUINAN MARK Executive Vice President & CFO | Grant or award · Non-Qualifed Stock Option (right to buy) | +40,120 | 40,120 | ||
| 2020-02-18 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Grant or award | +4,012 | 71,538 | ||
| 2020-02-18 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Grant or award · Non-Qualifed Stock Option (right to buy) | +26,165 | 26,165 | ||
| 2020-02-18 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Grant or award | +5,350 | 26,600 |
Page 45 of 52 · 1,040 trades